Last reviewed · How we verify

NCT06212856

Effects of 8 Week Plyometric Training on Physical Fitness and Technical Skills in Young Male Volleyball Players

Recruiting now NA Last updated 19 September 2024
What this trial tests

NA trial testing Plyometric training in Physical Fitness in 28 participants. Currently enrolling.

Timeline
15 January 2024
Primary endpoint
25 October 2024
25 November 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment28
Start date15 January 2024
Primary completion25 October 2024
Estimated completion25 November 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 25, male only, with Physical Fitness or Technical Skills. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to find the effectiveness of Plyometric training on Physical fitness and Technical skills of young male volleyball players. Players would be taken from Prime Sports Academy and Prime Institute of Health Sciences, Islamabad and a well-designed Plyometric training plan will be implied on them for 8 weeks. After the time span, the result would be compared to check the effectiveness of the training plan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Plyometric training

Trials testing the same drug.

Other recruiting trials for Physical Fitness

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06212856.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing